study parallels earlier study accompanying post lexapro life dr martin keller presumably primary investigator study found long term venlafaxine effexor use reduces risk depression fact said data showed venlafaxine extended release help prevent new episodes depression providing option millions adult patients depression experienced disappointing setback still seeking symptom relief please note i text document pr newswire indicating made statement i link text comments different dr susan kornstein quoted saying following long term effects lexapro findings indicate importance maintenance therapy patients recurrent major depressive disorder beyond four six months improvement even patient depressive symptoms appear resolved study effexor results published knowledge i gather study description study examined people effexor received sort therapeutic response taking kept taking effexor assigned take placebo course knowing switched placebo took effexor significantly less likely experience recurrence depressive symptoms compared placebo apparently effexor forever noted keller similar study kornstein say means stay meds long term prevent depression withdrawal effexor like kornstein keller absolutely misinterpreted evidence example one small study discontinuation venlafaxine associated adverse events patients compared patients stopped taking placebo another larger study found similarly effexor related increased rates discontinuation symptoms compared placebo frequent reports national medication hotline uk regarding discontinuation symptoms patients stop taking effexor addition also case reports experiencing shock like sensations venlafaxine withdrawal brief read shock like sensations check brief read british medical journal addition known paroxetine paxil another antidepressant healthy depressed volunteers times experienced depression upon ceasing taking medication given similar mechanism action effexor paxil one would expect similar result effexor quote dr david healy helps summarize fundamental manipulation evidence drug companies allied independent academics clear companies must known certain proportion patients randomised placebo subsequently complained depressive anxiety symptoms suffering withdrawal problems withdrawal problems however appear used basis claiming continued ssri intake prophylactic effect nervous depressive problems based studies companies sought received licences make claims regarding prophylaxis words ssris similar drugs effexor withdrawal symptoms sometimes lead depression looks like effective preventing depression people often get worse shortly stopping medication drug companies wyeth case effexor would like believe means antidepressants protect experiencing depression get better good long term treatment accurate statement antidepressants protect substantial withdrawal symptoms stop taking see withdrawal mention withdrawal i say personal affront keller kornstein academic made public statements regarding long term efficacy antidepressants seems odd anyone particularly anyone research credentials could ignore solid evidence substantial withdrawal symptoms associated antidepressants many researchers apparently continue toe line drug companies depression drug causes depression return current verdict long term outcomes depression indeed nasty condition often returns successfully treated vanishes due passage time yes treat however let keep mind antidepressants barely effective placebo short term see lead problems long term one either choose stay years antidepressant perhaps indefinitely good chance risking heinous withdrawal effects psychotherapy much better long run depression still positively impact many people like psychotherapy depression best though limited success rate perhaps due solely lack causing withdrawal effects least causing much lower rate meds